All Bookmarks

4-8 June - Clinical Pharmacokinetic studies for HIV, TB and Malaria

The University of Cape Town’s (UCT) Division of Clinical Pharmacology, in association with Trials of Excellence in Southern Africa (TESA), presents an interactive 5-day workshop on the theoretical & practical aspects of designing, organising & analysing pharmacokinetic-pharmacodynamic (PK-PD) clinical research projects.

Saved once (save to my bookmarks)
Bookmarked by Zuri Otieno on 13 Feb 2012
0 points

World TB Day 2012: Strengthening tuberculosis research in Africa

On the occasion of World Tuberculosis (TB) Day, 24 March 2012, the European and Developing Countries Clinical Trials Partnership (EDCTP) has published a short video that highlights some of the EDCTP funded TB research in sub-Saharan Africa.

In addition, this article presents several areas of development: new diagnostic tools, shorter treatment periods, prevention of TB, and safe treatment combinations in TB-HIV co-infected patients.

Saved once (save to my bookmarks)
Bookmarked by The Editorial Team on 27 Mar 2012
0 points

Ecole Doctorale Régionale d'Afrique Centrale en Infection Tropicale

L'école Doctorale Régionale d'Afrique Centrale en Infection Tropicale ouvrira ses portes dès Octobre 2011-2012. Notre École ouvre un Master recherche en Infectiologie Tropicale .
Dans le cas où ce Master intéresseraient des candidats d'afrique de l'ouest, veuillez visiter notre site pour plus d'informations.

Nous restons disponibles pour d'éventuelles remarques.
Secrétariat du Directeur Général de l'EDR
Axelle MENGUE
BP 876 Franceville

Saved once (save to my bookmarks)
Bookmarked by Frida OYAKHIROMEN on 28 Jun 2011
0 points

Developing New Drugs and Vaccines for Neglected Diseases of the Poor: Product Developer Landscapes

Using collected and reviewed data from the BIO Ventures for Global Health (BVGH) Global Health Primer, a new document has been compiled to shed light on the different types of organizations that are participating in product development for a broad range of neglected diseases. The results of this analysis are detailed in a new report, "Developing New Drugs and Vaccines for Neglected Diseases of the Poor: The Product Developer Landscape", available at the link above.

Saved once (save to my bookmarks)
Bookmarked by The Editorial Team on 2 Apr 2012
0 points

Experts give top concerns on genetic tests

Written by John Donnelly on February 2, 2012

In the final session today before the Presidential Commission for the Study of Bioethical Issues, Chair Dr. Amy Gutmann asked all the experts who presented information to talk about their greatest concern with genetic tests.

Gutmann, the President of the University of Pennsylvania, told them: “The Commission is very likely to focus its report on issues of privacy broadly construed. Anything that is relevant to privacy would be of great interest to the Commission.”

Among the responses:

Jane Kaye, Director of the Centre for Law, Health and Emerging Technologies at Oxford University: “I would say I see the whole genome sequencing is another twist on things happening already on science. … What we need to do is make (privacy concerns) more nuanced and allow individuals to say how whole genomes are used.”

See link for the rest of this blogpost

Saved once (save to my bookmarks)
Bookmarked by Dina Bogecho on 9 Feb 2012
0 points